SPECIES-SPECIFIC CARE · OWNER EDUCATION
Equine joint injections and regenerative therapies
Understanding treatment goals, evidence limits, procedure risks, and rehabilitation before choosing an equine joint therapy.
Before making a decision
This guide supports discussions with the professional responsible for your animal’s care. The species listed are the scope of the article; individual procedures, medications and preparation instructions still depend on the patient. Ask for a written plan that explains the goal, alternatives, expected response and when to call.
Do not change a prescription, fasting plan, feeding method or bandage based on another animal’s experience. If the instructions are unclear, contact the treating team before proceeding.
Start with the cause of lameness
A joint injection delivers a treatment into a particular joint; regenerative or biologic therapies use preparations intended to influence inflammation or tissue repair. Neither description establishes that a horse needs the treatment. The first question is which structure is causing pain and what diagnosis is supported. AAEP performance-horse guidance warns against joint injections without a specific medical indication.
A lameness assessment may include examination, observation of movement, diagnostic pain-localizing techniques, and imaging. Bring the history of onset, work changes, previous injuries, and previous injections. If possible, bring existing records and images so the veterinarian can distinguish a recurring problem from a new one. Similar-looking lameness can have different causes and treatment priorities.
What the different options mean
Common discussions include anti-inflammatory joint medications and biologic preparations such as platelet-rich plasma, conditioned blood products, or cell-based therapies. Platelet-rich plasma is prepared from blood and contains concentrated platelets and other components. Its composition varies with the processing method. Cell-based products also differ in their origin and preparation, so a broad label such as stem cells is not a complete treatment description.
Cornell's equine services describe regenerative treatments alongside conventional orthopedic care. Owners should understand them as options within a larger plan rather than proof that damaged cartilage will regrow. Ask for the exact product or preparation, the target structure, its intended action, and whether the proposed use is supported by evidence for this particular diagnosis.
Interpreting benefits and uncertain evidence
A treatment may be intended to reduce pain, improve function, support rehabilitation, or influence the course of a disease. Those are different outcomes. Ask what success would look like for your equine: more comfortable turnout, return to a defined activity, or measurable improvement at a follow-up examination. Establishing the goal before treatment helps prevent a temporary change from being mistaken for complete healing.
Published evidence is not equally strong for all products and conditions. A systematic review of platelet-rich plasma for equine joint disease found conflicting evidence. Study designs, preparation methods, and patient populations differ. Results from tendon injuries or laboratory work do not automatically establish benefit in naturally occurring joint disease. No injection can promise a return to competition or a permanent cure.
Preparing and giving informed consent
Discuss current medications, recent illness, previous reactions, metabolic disease, and all competition obligations before scheduling. The veterinarian should decide whether these change the choice or timing of treatment. Competition medication rules vary by organization and can change; request current written guidance from the responsible authorities rather than treating a familiar withdrawal interval as universally valid.
Ask for an estimate that includes diagnostics, preparation, the procedure, rehabilitation visits, and possible repeat treatment. Clarify what the team will do if the examination on the day identifies a different problem. A useful consent conversation includes alternatives such as management changes, conventional pain control, surgery, rehabilitation, or choosing comfort-focused care when a return to previous work is unrealistic.
The professional procedure
The team identifies the intended site, prepares it carefully, and uses sterile technique. Sedation or other restraint may help keep the equine and personnel safe. Some biologic treatments require collection and processing of blood or tissue, while others are supplied as prepared products. Ask how the material is identified, handled, and linked to this patient when preparation involves several steps.
AAEP proceedings emphasize sterile site preparation and injection technique because introducing infection into a joint can have serious consequences. This is a veterinary procedure, not an owner-administered injection. If imaging guidance, sample collection, or additional testing is recommended, ask which uncertainty it addresses. Not every injection looks the same because joints, surrounding structures, and treatment preparations differ.
Risks and species limitations
Possible complications include post-treatment inflammation, infection, bleeding, an adverse reaction to the product, and inadequate response. Discuss which complications are most relevant to the selected preparation and the equine's health. A product made from the animal's own blood still requires careful handling and is not automatically free of risk.
Most equine clinical research concerns horses. Evidence for donkeys and mules may be more limited, and their assessment and medication choices require veterinary judgment. Do not extrapolate a horse's response, dose, or rehabilitation schedule simply by body size. Tell the veterinarian about the animal's normal behavior: subtle changes in willingness to walk or interact may be important when dramatic lameness is absent.
Rehabilitation is part of treatment
Obtain a written activity plan that states what is allowed now, how activity will progress, and what must be assessed before the next stage. Reduced pain does not prove the affected tissue can safely withstand its previous workload. Increasing exercise because the equine looks better can undermine the plan. Confirm how turnout, hand walking, ridden work, and farriery fit together for this case.
Tell the team if the recommended confinement or controlled exercise cannot be achieved safely. They may need to revise the plan rather than leave you with instructions that cannot be followed. Keep a short log of activity, medications, swelling, and comfort. Consistent observations are more useful than repeatedly testing the equine with strenuous work to see whether it is sound.
Recognizing trouble and assessing the result
Seek urgent veterinary advice for markedly increased lameness, refusal to bear weight, a hot or swollen joint, fever, or worsening pain after an injection. Do not assume these signs are a harmless treatment flare or wait for a routine recheck. The clinic should provide a contact route and clear instructions for unexpected changes before you leave.
At follow-up, compare the original goal with the actual response and the examination findings. Ask whether repeat treatment is justified, whether the diagnosis needs reconsideration, and what would make further injections inappropriate. The best decision may change as evidence and the animal's condition change. Comfort, safe function, and feasible long-term care remain meaningful outcomes even when previous athletic performance is unattainable.
Questions to ask your care team
- What diagnosis and pain-localizing evidence justify treating this joint?
- What is the exact preparation, and what evidence supports it for this condition?
- What complications require an urgent call, and who is available after hours?
- What rehabilitation milestones and reassessment will determine whether treatment helped?
Sources behind this guide
AAEP: Performance horse therapeutic guidanceVeterinary or animal-health guidance ↗Cornell: Regenerative therapiesVeterinary or animal-health guidance ↗Cornell: Regenerative medicine laboratory servicesVeterinary or animal-health guidance ↗Equine Veterinary Journal: Systematic review of platelet-rich plasmaVeterinary or animal-health guidance ↗AAEP: Joint therapies proceedingsVeterinary or animal-health guidance ↗Content last reviewed: October 6, 2026. Review status: veterinary-informed; independent veterinarian review not yet completed.
Editorial standards and correctionsHow this library uses sources →